At present, Hejia Medical (300273) investor claim case is ongoing, and investors who meet the claim conditions can actively contact a lawyer to participate in the claim.
It is reported that the investor v. Hejia Medical (300273) ** has made new progress in the dispute over liability for false statements, and the Guangdong Provincial High People's Court made a second-instance judgment rejecting Hejia Medical's appeal request, and the investor won the final trial.
Hejia Medical (300273) announced on July 6, 2023 that the company** had been terminated by the Shenzhen Stock Exchange and was delisted on July 6. Although Hejia Medical (300273) has been delisted, this will not affect investors' claims, so investors who have not yet participated in the claims can continue to file claims and recover their losses through judicial channels.
Cause of Claim
On March 28, 2023, Hejia Medical (300273) received the "Administrative Penalty Decision" issued by the Guangdong Regulatory Bureau, and was punished by the CSRC for false statements in accordance with the law. Investors who have suffered losses due to the misrepresentation of Hejia Medical (300273) can join the rights protection team as soon as possible.
Hejia Medical (300273) won the final trial, and investors in this case whose claim conditions are between January 7, 2020 and April 20, 2022**Hejia Medical (300273)** and sold or continued to hold ** after April 20, 2022 can file a claim (the final result is subject to the court's determination).